"We won't have a faggot in our house."Those are the words M heard after his mother died of cancer. He was 16. His mom had loved and accepted him. But not his aunt and uncle. They took in his little brother, but left M to fend for himself in the streets.M lived in a town in Florida that had no youth shelter. Show More Summary
Don Schumacher, one of the most successful team owners in NHRA drag racing, had surgery Wednesday to treat a form of skin cancer, his team said.
Cincinnati Bengal’s defensive tackle Devon Still has responded to allegations that he has paid no child support for his daughter Leah, who is battling cancer. Still says the allegations are completely untrue, reports ESPN. On Wednesday, Still publicly addressed allegations made by Leah’s mother that he had not paid child support in months. Show More Summary
A major breakthrough in developing a new therapy for advanced bladder cancer -- for which there have been no major treatment advances in the past 30 years -- has been made by scientists. The study examined an antibody (MPDL3280A) which blocks a protein (PD-L1) thought to help cancer cells evade immune detection.
After surviving colon and pancreatic cancer in the past, 81-year-old Justice Ginsburg is reportedly ‘resting comfortably’ after cardiac surgery Wednesday.
Scientists may be able to detect cancer risk in the blood much, much earlier
More public health interventions, along the lines of the smoking ban, are needed to tackle the devastating toll of 'lifestyle' diseases, including heart disease and cancer, according to academics.
Enzymes inside cells that normally repair damaged DNA sometimes wreck it instead, researchers have found. The insight could lead to a better understanding of the causes of some types of cancer and neurodegenerative disease.
A deeper understanding of how KRAS turns off tumor suppressor genes and identifies a key enzyme in the process has been gained by researchers. The findings suggest that this enzyme, known as TET1, may be an important target for cancer diagnostics and treatment.
The unusual role of lactate in the alveolar soft part sarcoma has been uncovered by researchers who also confirm that a fusion gene is the cancer-causing agent in the disease.
Johns Hopkins researchers report that their test of an interventional X-ray guidance device approved by the U.S. Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy (IAT) for liver cancer.
An team of researchers has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice, they report.
BOSTON - A promising experimental immunotherapy drug works best in patients whose immune defenses initially rally to attack the cancer but then are stymied by a molecular brake that shuts down the response, according to a new study led by researchers at Dana-Farber Cancer Institute and the Yale University School of Medicine. read more
It is so unfortunate that Amendment 2 failed in Florida. Florida is a state that already has access to medical marijuana but only for a tiny percentage of patients, those with epilepsy or cancer. Amendment 2 was going to allow the Florida...Show More Summary
Scientists from Queen Mary University of London have made a breakthrough in developing a new therapy for advanced bladder cancer - for which there have been no major treatment advances in the past 30 years. Published today in Nature, the study examined an antibody (MPDL3280A) which blocks a protein (PD-L1) thought to help cancer cells evade immune detection. read more
In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University School of Medicine in St. Louis has brought the approach one step closer to reality. read more
The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found. The study, led by a Yale Cancer Center investigator, is described in the Nov. 27 edition of the journal Nature.
LOS ANGELES - November 26, 2014 - Work supported by the Stand Up To Cancer (SU2C) - Cancer Research Institute (CRI) - Immunology Translational Research Dream Team, launched in 2012 to focus on how the patient's own immune system canShow More Summary
The mother of Leah Still, the daughter of Devon Still whose cancer battle has helped raise millions of dollars for research, has hired high-powered attorney Gloria Allred in an attempt to recoup allegedly missed child support payments...Show More Summary
Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving cell growth and division, but...Show More Summary